AMIX vs. XAIR, LFWD, VVOS, PETV, NRXS, PAVM, ALUR, CODX, ICU, and BSGM
Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Beyond Air (XAIR), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), PetVivo (PETV), NeurAxis (NRXS), PAVmed (PAVM), Allurion Technologies (ALUR), Co-Diagnostics (CODX), SeaStar Medical (ICU), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry.
Autonomix Medical vs.
Autonomix Medical (NASDAQ:AMIX) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.
Autonomix Medical has higher earnings, but lower revenue than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.
Autonomix Medical has a net margin of 0.00% compared to Beyond Air's net margin of -1,730.00%. Autonomix Medical's return on equity of -212.48% beat Beyond Air's return on equity.
10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 20.1% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Autonomix Medical presently has a consensus target price of $28.00, suggesting a potential upside of 1,321.32%. Beyond Air has a consensus target price of $3.67, suggesting a potential upside of 1,646.03%. Given Beyond Air's higher probable upside, analysts plainly believe Beyond Air is more favorable than Autonomix Medical.
Beyond Air received 47 more outperform votes than Autonomix Medical when rated by MarketBeat users. However, 100.00% of users gave Autonomix Medical an outperform vote while only 69.57% of users gave Beyond Air an outperform vote.
In the previous week, Autonomix Medical and Autonomix Medical both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.63 beat Beyond Air's score of -0.18 indicating that Autonomix Medical is being referred to more favorably in the media.
Autonomix Medical has a beta of -3.08, suggesting that its share price is 408% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500.
Summary
Beyond Air beats Autonomix Medical on 9 of the 16 factors compared between the two stocks.
Get Autonomix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Autonomix Medical Competitors List
Related Companies and Tools
This page (NASDAQ:AMIX) was last updated on 4/24/2025 by MarketBeat.com Staff
Buy AMIX Stock Free AMIX Stock Alerts